Hormonal breast enhancement or augmentation is a highly experimental potential medical treatment for the breasts in which hormones or hormonal agents such as estrogenprogesteronegrowth hormone GHand insulin-like growth factor 1 IGF-1 are utilized or manipulated to produce breast enlargement in women.
In addition to pharmaceuticalssome herbal breast enlargement supplements contain phytoestrogens such Transsexual hormone breast growth 8-prenylnaringenin found in hops and miroestrol a constituent of Pueraria mirifica and thus may be regarded as a form of hormonal breast enhancement. The administration of estrogen to women with Turner syndromewho normally do not develop breasts due to hypogonadismresults in normal pubertal breast development.
Systemic administration of GH or IGF-1 causes mammary hyperplasia Transsexual hormone breast growth of the mammary glands in animals.
In women with Laron syndromewhere the growth hormone receptor GHR is defective and insensitive to GH and serum IGF-1 levels are very low, puberty, including breast development, is delayed, although full sexual maturity is always eventually reached.
An adolescent Vietnamese girl with Laron syndrome who was treated with a high dosage of IGF-1 and a gonadotropin-releasing hormone analogue "Transsexual hormone breast growth" 3—4 years paradoxically experienced isolated progression of breast development without any other pubertal changes in spite of estrogen levels in the low prepubertal range.
Certain long-acting growth hormone secretagoguessuch as CJC  and ibutamoren MK are capable of reliably and effectively increasing serum GH and IGF-1 concentrations in humans. A number of dietary supplements
Transsexual hormone breast growth L -arginineL -ornithineL -lysineacetyl- L -carnitineand creatinemay be able to significantly increase GH levels, although evidence is mixed.
Progesterone and non- androgenic progestinssuch as dydrogesteronedo not affect serum IGF-1 levels regardless of route of administration. Diet and Transsexual hormone breast growth have been found to affect serum IGF-1 levels. Androgenssuch as testosterone and dihydrotestosterone DHTpowerfully suppress the action of estrogen in the breasts. Cyclooxygenase-2 COX-2 overexpression in mammary gland tissue produces mammary gland hyperplasia as well as precocious mammary gland development in female mice, indicating a strong stimulatory effect of this enzyme on the growth of the mammary glands.
The risk of breast cancer in women is approximately fold that of men. From Wikipedia, the free encyclopedia. Mansel; Oystein Fodstad; Wen G. Jiang 14 June Metastasis "Transsexual hormone breast growth" Breast Cancer. Cold Spring Harb Perspect Biol. J Mammary Gland Biol Transsexual hormone breast growth. Baxter 31 July Insulin-like Growth Factor Receptor Signalling.
Management of Breast Diseases. Allanson 20 September Management of Genetic Syndromes. Transsexual and Other Disorders of Gender Identity: A Practical Guide to Management. Levine 3 October Kopchick 25 November Laron Syndrome - From Man to Mouse: Lessons from Clinical and Experimental Experience.
The Personal Experience —". Doyle 3 February Nutrition for Sport and Exercise. Driskell 25 June Essentials of Sports Nutrition. Audette; Transsexual hormone breast growth Bailey 26 February Wallig 1 May Haschek and Rousseaux's Handbook of Toxicologic Pathology. Camacho 26 September Ditmier 1 January New Developments in Obesity Research. Dietz 15 April Clinical Obesity in Adults and Children. Mechanisms and Clinical Management.
Barbieri 13 September Yen and Jaffe's Reproductive Endocrinology. Klein 24 February Contemporary Issues in Prostate Cancer: Aronson 2 March Meyler's Side Effects of Cardiovascular Drugs.
Principles and Practice of Endocrinology and Metabolism. Archer 21 May J Cell Mol Med. A Study on Patients". A Dynamic Encyclopedia of Disease Mechanisms.
Managing Breast Cancer Risk. Berger 19 June Murine Transsexual hormone breast growth, Energy Balance, and Cancer. Bodybuilding supplement Breast enlargement supplement Clitoris enlargement Ergogenic use of anabolic steroids Growth hormone therapy Hormonal breast enhancement Transgender hormone therapy Feminizing hormone therapy Masculinizing hormone therapy Penis enlargement Performance-enhancing substance. Retrieved from " https: Body modification Breast Endocrine procedures.
Views Read Edit View history.
In the. In transgender men, or transmasculine people (FTM), the most common Administration of estrogen (via oral, sublingual, transdermal or intramuscular routes) secondary sex characteristics including: breast growth and female- Transsexual hormone breast growth fat.
This is my 6 month boob update on hormone replacement therapy for transgender male to female. I've been on hrt for a little over 6 months and.